Kingswood Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,914
Closed -$267K 667
2024
Q1
$267K Sell
3,914
-570
-13% -$38.9K 0.03% 517
2023
Q4
$281K Buy
+4,484
New +$281K 0.03% 498